The U.S. Centers for Medicare and Medicaid Services wrote to the head of Oklahoma’s Medicaid agency that it has determined the federal government is entitled to part of Oklahoma’s proceeds.
US government seeks part of Oklahoma’s $270 million opioid deal
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain